Baptist Health Cancer Care to Present Research on Precision Radiation Therapy Across Complex Cancers at ASTRO 2026 - Top-Institutions - MDSpire

Baptist Health Cancer Care to Present Research on Precision Radiation Therapy Across Complex Cancers at ASTRO 2026

Experts across Baptist Health Herbert Wertheim Cancer Institute and Eugene M. & Christine E. Lynn Cancer Institute will present new radiation oncology research and clinical expertise at the 2026 Annual Meeting of the American Society for Radiation Oncology (ASTRO), September 26-30, 2026, in Boston.

  • By

  • July 7, 2026

  • 8 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Roswell Park Comprehensive Cancer Center
    Roswell Park Comprehensive Cancer Center

    Buffalo, New York

    Key Differentiators

    • Oncology
    • Radiation Oncology

  • #2

    Baptist Health Herbert Wertheim Cancer Institute
    Baptist Health Herbert Wertheim Cancer Institute

    Miami, Florida

    Key Differentiators

    • Oncology
    • Radiation Oncology

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Radiation Oncology

  • #4

    Eugene M. & Christine E. Lynn Cancer Institute
    Eugene M. & Christine E. Lynn Cancer Institute

    Boca Raton, Florida

    Key Differentiators

    • Oncology
    • Radiation Oncology

  • #5

    Fox Chase Cancer Center
    Fox Chase Cancer Center

    Philadelphia, Pennsylvania

    Key Differentiators

    • Oncology
    • Radiation Oncology

Original Source(s)

Baptist Health Cancer Care to Present Research on Precision Radiation Therapy Across Complex Cancers at ASTRO 2026

  • by

  • July 7, 2026

Related Content

Reconstruction of large truncal defects post-malignant tumor excision using triple rhomboid flaps

Improving CT-CBCT deformable image registration for cervical cancer adaptive radiotherapy using a deep learning approach

Cancer-related microangiopathic hemolytic anemia (CR-MAHA) in a metastatic breast cancer patient with a germ-line ATM single nucleotide variant and an ESR1 fusion variant: insights from a case report on early diagnosis and improved outcomes